Cargando…

Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report

Purpose: This study assessed the safety, feasibility, and tolerability of mesenchymal stem cells for patients diagnosed with COVID (Coronavirus disease 2019-induced ARDS (acute respiratory distress syndrome)). Materials and Methods: Critically ill adult COVID-19 patients who were admitted to Wonju S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwangmin, Bae, Keum Seok, Kim, Hyun Soo, Lee, Won-Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784973/ https://www.ncbi.nlm.nih.gov/pubmed/36556900 http://dx.doi.org/10.3390/medicina58121698

Ejemplares similares

Can bone marrow‐derived mesenchymal stem cells change liver volume?: A case report
por: Kim, Kwangmin, et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Neuron-Like Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells
por: Bae, Keum Seok, et al.
Publicado: (2011)

Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
por: Xiao, Kun, et al.
Publicado: (2020)

Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
por: Liang, Dan, et al.
Publicado: (2023)

Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
por: Li, Zhongwen, et al.
Publicado: (2020)

Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat
por: Kakabadze, Zurab, et al.
Publicado: (2022)

Outcomes improvement despite continuous visits of severely injured patients during the COVID-19 outbreak: experience at a regional trauma centre in South Korea
por: Kang, Sooyeon, et al.
Publicado: (2022)

Stem cell-based therapy for COVID-19 and ARDS: a systematic review
por: Zanirati, Gabriele, et al.
Publicado: (2021)

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Shetty, Ashok K., et al.
Publicado: (2021)

Mesenchymal stem cells in lung diseases and their potential use in COVID-19 ARDS: A systematized review
por: Armstrong, Bruna Benigna Sales, et al.
Publicado: (2023)

Effect of donor age on the proliferation and multipotency of canine adipose-derived mesenchymal stem cells
por: Lee, Jienny, et al.
Publicado: (2017)

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
por: Kim, Hyung Sook, et al.
Publicado: (2019)

The Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-Emphysema
por: Kim, You-Sun, et al.
Publicado: (2015)

The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats
por: Park, Won Beom, et al.
Publicado: (2010)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy for Patients with Post COVID ARDS on ECMO Referred for Lung Transplantation - Single Center Experience from India
por: Rahulan, V., et al.
Publicado: (2022)

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
por: Hashemian, Seyed-Mohammad Reza, et al.
Publicado: (2021)

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
por: Xu, Zhiheng, et al.
Publicado: (2021)

A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes
por: Chang, Youjin, et al.
Publicado: (2023)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Effectiveness of kaolin-impregnated hemostatic gauze use in preperitoneal pelvic packing for patients with pelvic fractures and hemodynamic instability: A propensity score matching analysis
por: Kim, Kwangmin, et al.
Publicado: (2020)

Erratum to "Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study"
por: Choi, Young Un, et al.
Publicado: (2023)

Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study
por: Choi, Young Un, et al.
Publicado: (2023)

Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment
por: Liu, Chang, et al.
Publicado: (2022)

The Flavonoid Glabridin Induces OCT4 to Enhance Osteogenetic Potential in Mesenchymal Stem Cells
por: Heo, June Seok, et al.
Publicado: (2017)

Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities
por: Moradinasab, Susan, et al.
Publicado: (2021)

Severe ARDS caused by adenovirus: early initiation of ECMO plus continuous renal replacement therapy
por: Ha, Sang Ook, et al.
Publicado: (2016)

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
por: Zarrabi, Morteza, et al.
Publicado: (2023)

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2022)

Adipose Tissue-Derived Mesenchymal Stem Cells Extend the Lifespan and Enhance Liver Function in Hepatocyte Organoids
por: Ock, Sun A, et al.
Publicado: (2023)

Experiences of the Emergency Department at the Pyeongchang Polyclinic During the 2018 PyeongChang Winter Olympic Games
por: Kim, Kwangmin, et al.
Publicado: (2019)

Skeletal muscle satellite cell-derived mesenchymal stem cells ameliorate acute alcohol-induced liver injury
por: Chung, Jae Sik, et al.
Publicado: (2022)

Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19
por: Murugan, Dhanashree, et al.
Publicado: (2022)

Likelihood of amyloid formation in COVID-19-induced ARDS
por: Sinha, Nabodita, et al.
Publicado: (2021)

Tracking Intravenous Adipose-Derived Mesenchymal Stem Cells in a Model of Elastase-Induced Emphysema
por: Kim, You-Sun, et al.
Publicado: (2014)

Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report
por: Ko, Pan-Woo, et al.
Publicado: (2021)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Gene Profiles in a Smoke-Induced COPD Mouse Lung Model Following Treatment with Mesenchymal Stem Cells
por: Kim, You-Sun, et al.
Publicado: (2016)

Adipose Mesenchymal Stem Cell Secretome Modulated in Hypoxia for Remodeling of Radiation-Induced Salivary Gland Damage
por: An, Hye-Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_424ee7j3n1ampg33elaeal1cdn